Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Gastrointestinal Stromal Tumors and ABCG2[original query] |
---|
Population pharmacokinetics and pharmacogenetics of imatinib in children and adults. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (21): 7102-9. Petain Aurélie, Kattygnarath Darouna, Azard Julie, Chatelut Etienne, Delbaldo Catherine, Geoerger Birgit, Barrois Michel, Séronie-Vivien Sophie, LeCesne Axel, Vassal Gilles, |
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors. The pharmacogenomics journal 2019 Feb . Verboom Michiel C, Kloth Jacqueline S L, Swen Jesse J, Sleijfer Stefan, Reyners Anna K L, Steeghs Neeltje, Mathijssen Ron H J, Gelderblom Hans, Guchelaar Henk-J |
Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug design, development and therapy 2023 3 17 809-820. Jiang Xuehui, Fu Qun, Jing Yan, Kong Ying, Liu Hong, Peng Hongwei, Rexiti Kaisaner, Wei Xiaoh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: